Identification of Five Tumor Antigens for Development and Two Immune Subtypes for Personalized Medicine of mRNA Vaccines in Papillary Renal Cell Carcinoma.

J Pers Med · 2023 · PMC9965942 · PMID 36836593

Europe PMC DOI

hedged sentence

0.1200

closest p · 2.4× alpha

0.1200

boldest claim

The sentences

showed a trendp = 0.12not close (p > 0.1)

The IS1 group showed a trend of decreased overall survival possibilities ( p = 0.12), and a larger sample size is needed to determine whether immunotypes could serve as a robust prognostic indicator for PRCC.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.